Abstract
Radiotherapy has an important role in the management of patients with cutaneous malignancy. Non-melanoma skin cancer (NMSC) is the most frequent malignancy worldwide, and as such the absolute number of patients receiving radiotherapy each year is high. An often and well-documented scenario is the development of a second NMSC, if not within a previous radiotherapy field, certainly in close proximity to a previous radiotherapy field, and therefore there may be a requirement to consider overlapping any new radiotherapy field with previously irradiated tissue, if other options are not considered. Published evidence for cutaneous re-irradiation is sparse especially as other options such as surgery are often available. Despite this select patients may be considered for re-irradiation, be that local or occasionally regional, especially where other options are not feasible.
The original version of this chapter was revised. An erratum to this chapter can be found at 10.1007/978-3-319-41825-4_78.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Babington S, Veness MJ, Cakir B, Gebski V, Morgan G (2003) Squamous cell carcinoma of the lip: does adjuvant radiotherapy improve local control following incomplete or inadequate excision? ANZ J Surg 73:621–625
Barton M (1995) Tables of equivalent dose in 2 Gy fractions: a simple application of the linear quadratic formula. Int J Radiat Oncol Biol Phys 31:371–378
Brotherston D, Poon I (2015) SBRT treatment of multiple recurrent auricular squamous cell carcinoma following surgical and conventional radiation treatment failure. Cureus 7, e325
Chao CKS, Gerber RM, Perez CA (1995) Reirradiation of recurrent skin cancer of the face. Cancer 75:2351–2355
Cognetta AB, Howard BM, Heaton HP et al (2012) Superficial x-ray in the treatment of basal and squamous cell carcinomas: a viable option in select patients. J Am Acad Dermatol 67:1235–1241
Duprez F, Madani I, Bonte K et al (2009) Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory. Radiol Oncol 93:563–569
Ferro M, Deodata F, Macchia G et al (2015) Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: A phase 2 study. Cancer Invest 33:34–38
Fogarty GB, Hong A, Scolyer RA et al (2014) Radiotherapy for lentigo maligna: a literature review and recommendations for treatment. Br J Dermatol 170:52–58
Gauden R, Pracy M, Avery AM et al (2013) HDR brachytherapy for superficial non-melanoma skin cancers. JMIRO 57:212–217
Gunaratne D, Howle J, Veness MJ (2016) Sentinel lymph node biopsy in Merkel cell carcinoma: a 15 year institutional experience and statistical analysis of 721 reported cases. BJD 174:273–281
Henderson MA, Burmeister BH, Ainslie J et al (2015) Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial. Lancet Oncol 16:1049–1060
Hernandez-Machin B, Borrego L, Gil-Garcia M, Hernandez BH (2007) Office-based radiation therapy for cutaneous carcinoma: evaluation of 710 treatments. Int J Dermatol 46:453–459
Hruby G, Scolyer RA, Thompson JF (2013) The important role of radiation treatment in the management of Merkel cell carcinoma. Br J Dermatol 169:975–982
Hong A, Fogarty G (2012) Role of radiation therapy in cutaneous melanoma. Cancer J 18:203–207
Kramkimel N, Dendal R, Bolle S, Zefkili S, Fourquet A, Kirova YM (2014) Management of advanced non-melanoma skin cancers using helical tomotherapy. JEADV 28:641–650
Marcil I, Stern RS (2000) Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol 136:1524–1530
Perera E, Gnaneswaran N, Staines C, Win AK, Sinclair R (2015) Incidence and prevalence of non-melanoma skin cancer in Australia: a systematic review. Austral J Dermatol 56:258–267
Porceddu S, Veness M, Guminski A (2015) Non-melanoma cutaneous head and neck cancer and Merkel cell carcinoma – Current concepts, advances and controversies. J Clin Oncol 33:3338–3345
Simmonds RH, Hopewell JW, Robbins ME (1989) Residual radiation-induced injury in dermal tissue: implications for retreatment. Br J Radiol 62:915–920
Smith SP, Grande DJ (1991) Basal cell carcinoma recurring after radiotherapy: a unique, difficult treatment subclass of recurrent basal cell carcinoma. J Dermatol Surg Oncol 17:26–10
Smith TL, Morris CG, Mendenhall NP (2014) Angiosarcoma after breast-conserving therapy: Long-term disease control and late effects with hyperfractionated accelerated re-irradiation (HART). Acta Oncol 53:235–241
Van Hezewijk M, Creutzberg CL, Putter H et al (2010) Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: analysis of 434 cases. Radiol Oncol 95:245–249
Veness MJ (2008) The important role of radiotherapy in patients with non-melanoma skin cancer and other cutaneous entities. JMIRO 52:278–286
Veness M, Howle J (2015) Radiotherapy alone in patients with Merkel cell carcinoma: the Westmead hospital experience of 41 patients. Australas J Dermatol 56:19–24
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Veness, M.J., Sundaresan, P. (2016). Re-irradiation for Recurrent Skin Cancer. In: Nieder, C., Langendijk, J. (eds) Re-Irradiation: New Frontiers. Medical Radiology(). Springer, Cham. https://doi.org/10.1007/174_2016_37
Download citation
DOI: https://doi.org/10.1007/174_2016_37
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-41823-0
Online ISBN: 978-3-319-41825-4
eBook Packages: MedicineMedicine (R0)